Summary:
Currently, a clinical research study (20100037) is under way to evaluate the safety and effectiveness of an investigational drug for people living with Subacute Cutaneous Lupus Erythematosus (SCLE) every day.
Qualified Participants Must:
• Be 18 to 70 years of age
•
Have a confirmed diagnosis of Subacute Cutaneous Lupus Erythematosus
•
Meet other eligibility criteria that will apply
Qualified Participants May Receive:
Study-related medication and study related examinations and care and compensation for time and travel may be provided.